SpeedWeed

APRIL 9, 2021

Eighty percent of all respondents said they were using weed to help with chronic pain, and 52 percent of veteran respondents said they used it for PTSD. . The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed. View original article.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

MMJ Recs

APRIL 1, 2024

From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions. Studies have suggested that CBD may help manage chronic pain, reduce anxiety and depression, alleviate symptoms of epilepsy, and even aid in cancer treatment.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

LifeCannMD

NOVEMBER 24, 2023

Medical marijuana may be recommended for conditions such as chronic pain, epilepsy, multiple sclerosis, Crohn’s disease, cancer, and other qualifying conditions. Medical marijuana is known for its potential to alleviate symptoms like pain, nausea, muscle spasms, and seizures.

Marijuana 52

Marijuana Chronic Pain Conditions Strains 52

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. For too long, America has relied too heavily on opioids for pain relief. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 23, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

MGC Pharma

FEBRUARY 22, 2018

An increasing number of older people are seeking the treatment for conditions such as inflammatory arthritis, autoimmune disease and chronic pain. Unfortunately, the regulatory process is fraught with bottlenecks, with no more than 500 Australians having legal access to Medical Cannabis. namely Australia’s aging population.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

MedicalJane

OCTOBER 28, 2022

Millions of Americans, especially older individuals, are turning to medical marijuana for managing their chronic pain symptoms. This increasing number of states that have legalized medical marijuana makes it easier for patients to obtain a prescription from their doctor, making it more accessible than ever before.

Marijuana 86

Marijuana Chronic Pain Medicine Pharmaceutical 86

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Veriheal

APRIL 21, 2022

It is a great day indeed especially for patients suffering from chronic pain—like medical cannabis advocate Pearl Schomburg—who can finally access this excellent alternative to other risky pharmaceutical treatments. .

Chronic Pain 97

Chronic Pain Pharmaceutical Medicine Patients 97

Canna Care Docs

DECEMBER 11, 2018

However, with medical cannabis continuing to spread through the country—and with more and more research pointing to its benefits for everything from chronic pain and sleep problems to anxiety and arthritis—the tide seems to be turning. Numerous studies point to that fact, especially in cases surrounding chronic pain and discomfort.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

The Cannigma

JUNE 25, 2022

Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. These products are typically more accessible in larger cities.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

MMJ Recs

FEBRUARY 18, 2024

These may include chronic pain, nausea and vomiting related to chemotherapy, muscle spasms, seizures, and mental health disorders. One of the most well-known applications is pain relief, particularly for chronic pain, arthritis, and neuropathic pain.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Cannabis Law Report

APRIL 1, 2022

CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join in 21 years. It also owns a majority stake in LVL Health , a chronic pain clinic, alongside a minority stake in cannabinoid-based biopharmaceutical company Kingdom Therapeutics.

Chronic Pain 52

Chronic Pain Pharmaceutical Sativa Business 52

Veriheal

AUGUST 9, 2023

CBD, Trema micrantha, and the Study’s Significance CBD means cannabidiol , one of over a hundred compounds in the cannabis plant, and is widely celebrated as a potential treatment for a long list of health concerns, including chronic pain , epilepsy , i nsomnia , anxiety , and skin allergy.

CBD 96

CBD Cannabinoids THC Extraction 96

MMJ Recs

FEBRUARY 3, 2024

Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. This can lead to a decreased reliance on pharmaceuticals that may adversely affect patients’ health and overall lifestyle.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Cannabis Law Report

JUNE 7, 2019

The farm is run by GW Pharmaceuticals, where around two million cannabis plants have been produced since its opening in 1998. Those suffering from epilepsy, nausea and chronic pain due to chemotherapy are now given the option to get the drug on prescription, reports The Mirror . Something has finally happened in Sittingbourne.

Chronic Pain 40

Chronic Pain Epilepsy Legalization Pharmaceutical 40

Veriheal

AUGUST 13, 2020

THC is primarily responsible for the psychoactive effects users feel, and it also helps to combat nausea, increase appetite, encourage sleep, and relieve chronic pain. EPM-301 takes its name from the company EPM, a startup dedicated to bridging the gap between organic cannabis and the needs of pharmaceutical companies.

Cannabinoids 98

Cannabinoids Chronic Pain Sleep Pharmaceutical 98

MMJ Recs

JANUARY 22, 2024

CBD edibles, ranging from gummies to infused snacks, provide a discreet and precisely dosed method for individuals seeking relief from conditions such as anxiety, chronic pain, and insomnia. Meanwhile, THC-dominant edibles can be instrumental in alleviating symptoms associated with chronic pain and enhancing overall well-being.

Edibles 52

Edibles Marijuana Chronic Pain THC 52

Cannabis Law Report

NOVEMBER 23, 2021

The products to be manufactured at the facility aren’t specified, but will be used for managing chronic pain, epilepsy, multiple sclerosis, and pain associated with palliative care. The subject land is zoned RU1 Primary Production. Further information on the proposed project can be found here.

Chronic Pain 52

Chronic Pain Epilepsy Environment Pharmaceutical 52

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 87

Chronic Pain Pharmaceutical Patients Epilepsy 87

Veriheal

JUNE 20, 2022

The FDA has also approved a few cannabis-based pharmaceutical drugs. Cannabis legalization is already showing that places with legal access to cannabis are seeing a drop in dependency on pharmaceutical prescriptions. Cannabis is helping patients fight cancer, control seizure disorders, fight chronic pain, and so much more.

Chronic Pain 97

Chronic Pain Advocacy Pharmaceutical Legalization 97

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Other common health problems include tinnitus, hearing loss, and lower-back pain. What is the VA’s Position of Medical Marijuana?

Access 49

Access Marijuana Research and Development Programs 49

Weedistry

DECEMBER 29, 2018

Most of the wave of incoming leaders after our recent midterm elections, at the state and federal level, support expanding access to medical marijuana. I previously worked as an emergency room doctor and have witnessed firsthand how helpful this drug can be for patients struggling with chronic pain and a myriad of symptoms.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45

MMJ Recs

MAY 15, 2022

But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Medical marijuana products are produced and sold in Virginia by businesses called “pharmaceutical processors”. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

DECEMBER 14, 2019

Upon receipt of a Controlled Drug License from the UK Home Office, after last week’s inspection, Farmako Limited will be fully licensed to pursue pharmaceutical/medical cannabis trading within the UK operating theatre. Recent UK legislation allows for the prescription of cannabis from medical specialists through a regular pharmacy model.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

The Cannigma

AUGUST 25, 2021

It’s important to note that Italy often suffers shortages in cannabis products, as that all medical cannabis prescribed in Italy must be produced by the Military Chemical Pharmaceutical Plant, or else imported from Canada or the Netherlands. Can foreigners access medical marijuana? How to get medical marijuana in Italy.

Legalization 52

Legalization Chronic Pain Decriminalization Conditions 52

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. (In

History 56

History Legalization Chronic Pain Pharmaceutical 56

NORML

FEBRUARY 1, 2019

Click here to email your lawmakers in support of banking access. Legislation is pending, House Bill 5442, to expand patients’ access to medical cannabis in Connecticut. The measure would expand the pool of individuals eligible for medical cannabis by allowing physicians to recommend it to those with generalized chronic pain.

Legislation 167

Legislation Decriminalization Access Patients 167

Cannabis Law Report

JANUARY 19, 2022

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. Greenrise Global Logo (CNW Group/Greenrise Global Brands Inc.). ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

MMJ Recs

NOVEMBER 7, 2022

A physical MMJ card is easily accessible, less prone to damage, and can be stored easily in your wallet. Chronic Pain. In Virginia, medical marijuana products are produced and sold by businesses called “pharmaceutical processors”. The Virginia Board of Pharmacy has issued permits to five pharmaceutical processors.

Marijuana 52

Marijuana Chronic Pain Dispensary Pharmaceutical 52

Cannabis Law Report

JANUARY 4, 2022

In addition, the surge in medical marijuana production owing to its increasing demand in the pharmaceutical sector is further propelling overall growth. Lower market access to cannabis due to absence of legalization programs, leading to smuggling. Mgc Pharmaceuticals Ltd. Australia Legal Cannabis Market Report Highlights.

Legalization 52

Legalization Supply Chain Chronic Pain Sleep 52

Cannabis Law Report

NOVEMBER 14, 2019

Barriers confronting patients trying to access medicinal cannabis in Australia will be scrutinised in a Parliamentary inquiry into how the drug is regulated. The Greens said the medicinal cannabis system is “broken” and in urgent need of reform as their push for an inquiry into access to the drug won support in the Senate on Thursday.

Access 49

Access Medicine Chronic Pain Patients 49